Epidemiological Characteristics of Notifiable Respiratory Infectious Diseases in Mainland China from 2010 to 2018
暂无分享,去创建一个
Dayan Wang | G. He | Gui-lian Li | Jinlong Wang | Hai-can Liu | Lele Deng | Yajun Han
[1] N. Song,et al. Analysis of influenza trend and impact of COVID‐19 in Kezhou, Xinjiang for 8 consecutive years , 2022, Journal of medical virology.
[2] M. Jit,et al. Regional-based within-year seasonal variations in influenza-related health outcomes across mainland China: a systematic review and spatio-temporal analysis , 2022, BMC Medicine.
[3] L. Fang,et al. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic , 2021, Nature Communications.
[4] Sung-il Cho,et al. Recent increase in pertussis incidence in Korea: an age-period-cohort analysis , 2021, Epidemiology and health.
[5] R. Bergquist,et al. Spatio-temporal epidemiology of the tuberculosis incidence rate in Iran 2008 to 2018 , 2021, BMC Public Health.
[6] Wei-bing Wang,et al. Temporal Trends in Notification and Mortality of Tuberculosis in China, 2004–2019: A Joinpoint and Age–Period–Cohort Analysis , 2021, International journal of environmental research and public health.
[7] Xiuhua Guo,et al. Changes in Incidence and Epidemiological Characteristics of Pulmonary Tuberculosis in Mainland China, 2005-2016 , 2021, JAMA network open.
[8] Xiling Wang,et al. Influenza-associated disease burden in mainland China: a systematic review and meta-analysis , 2021, Scientific reports.
[9] Ruibai Wang,et al. Epidemiological characteristics and trends of notifiable infectious diseases in China from 1986 to 2016 , 2020, Journal of global health.
[10] G. Patton,et al. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017 , 2020, BMJ.
[11] Jinlin Liu,et al. Notifiable Respiratory Infectious Diseases in China: A Spatial–Temporal Epidemiology Analysis , 2020, International journal of environmental research and public health.
[12] Hui Zhang,et al. Incidence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study , 2020, Infectious Diseases of Poverty.
[13] Hong Yang,et al. Progress Toward Measles Elimination — China, January 2013–June 2019 , 2019, MMWR. Morbidity and mortality weekly report.
[14] L. Liu,et al. [Influenza-like illness outbreaks in China during 2017-2018 surveillance season]. , 2019, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].
[15] Jinlin Liu,et al. A descriptive analysis of the Spatio-temporal distribution of intestinal infectious diseases in China , 2019, BMC Infectious Diseases.
[16] Lin Zhou,et al. The role of tuberculosis control institutes in delivering TB information to domestic migrants in China: a multi-level analysis of a nationwide cross-sectional survey. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[17] Patricia C Lee,et al. Global Geographical and Temporal Patterns of Seasonal Influenza and Associated Climatic Factors. , 2019, Epidemiologic reviews.
[18] Jan Kyncl,et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.
[19] Yonggen Jiang,et al. Influence of infectious disease seasonality on the performance of the outbreak detection algorithm in the China Infectious Disease Automated-alert and Response System , 2017, The Journal of international medical research.
[20] Wenbo Xu,et al. Global and national laboratory networks support high quality surveillance for measles and rubella. , 2017, International health.
[21] B. Cowling,et al. Edinburgh Research Explorer Seasonal influenza vaccination in China , 2022 .
[22] Thomas Belcher,et al. Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[23] Matthew J Thompson,et al. Translating diagnostic assays from the laboratory to the clinic: analytical and clinical metrics for device development and evaluation. , 2016, Lab on a chip.
[24] Christopher Gilpin,et al. WHO's new End TB Strategy , 2015, The Lancet.
[25] M. Kulldor,et al. Prospective time-periodic geographical disease surveillance using a scan statistic , 2001 .
[26] E. Feuer,et al. Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.